N@N

The Shuman Law Firm Investigates Amedisys, Inc.

^{Published on 2010-06-18 17:20:29 - Market Wire}
 

BOULDER, Colo.--([ BUSINESS WIRE ])--The Shuman Law Firm today announced that it is investigating potential breaches of fiduciary duty by certain officers and directors at Amedisys, Inc. (aAmedisysa or the aCompanya) (NASDAQ: AMED). Amedisys provides home health and hospice services, including skilled nursing and home health aide services, physical, occupational and speech therapy, and medically oriented social work to individuals who require ongoing care.

"deliberately boosted the number of home therapy visits to trigger higher Medicare reimbursements."

The investigation concerns allegations that the Company has been taking advantage of the Medicare reimbursement system by increasing the number of in-home therapy visits to their clients, some of which were allegedly not medically necessary. On May 13, 2010, the Wall Street Journal reported that the Senate Finance Committee (the aCommitteea) had launched an investigation into whether Amedisys and certain other in-home therapy providers adeliberately boosted the number of home therapy visits to trigger higher Medicare reimbursements.a The Committee sent letters to the chief executives of the companies requesting information about the companiesa™ therapy visits from 2006 through 2009 and their financial relationships with referring physicians.

If you currently own shares of Amedisys and are interested in discussing your rights as an Amedisys shareholder, or have information relating to this investigation, please contact Kip B. Shuman or Rusty E. Glenn toll free at (866) 974-8626 or email Mr. Shuman at [ kip@shumanlawfirm.com ] or Mr. Glenn at [ rusty@shumanlawfirm.com ].

The Shuman Law Firm represents investors throughout the nation, concentrating its practice in securities class actions and shareholder derivative actions.